New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 25, 2014
10:41 EDTXNPTClinton Group seeks three members on XenoPort board
Clinton Group issued a proxy statement to XenoPort shareholders seeking to elect three independent director nominees to the company's board. Clinton told shareholders, "We do not believe that the current board of directors of the Company is acting in the best interests of the Company’s stockholders."
News For XNPT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 11, 2015
15:05 EDTXNPTXenoPort believes FDA accepeted NIAAA design for Horizant trial
Subscribe for More Information
15:04 EDTXNPTXenoPort says Horizant 13-week prescriptions increased 18%
XenoPort reported an update on prescription trends and further development of Horizant Extended-Release Tablets, including feedback from the FDA on development for treatment of alcohol use disorder. Horizant prescription trend highlights include: The number of nation-wide prescribed tablets for the 13 weeks ending December 19, 2014 was 1,256,082, an increase of 18% compared to the prior 13 weeks ending September 19, 2014 and an increase of 95% over the 13-week period ending December 20, 2013. The rolling four-week average of prescribed tablets for the week ending December 19, 2014 was 100,742. The current wholesale acquisition cost price is $7.69 per tablet. During Q3, XenoPort increased its field sales force of NeuroHealth Sales Specialists from approximately 40 to 65 representatives. The number of prescribed tablets for the 13 weeks ending December 19, 2014 in the territories occupied by the new NHS Specialists was 227,897, an increase of 46% compared to the 13 weeks ending June 27, 2014, which was prior to the addition of the new NHS Specialists.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use